Adaptimmune Therapeutics plc

ADAPY ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Aug 15, 2025
144 Aug 15, 2025
8-K Aug 14, 2025 8-K
SCHEDULE 13G/A Aug 13, 2025
10-Q Aug 13, 2025 10-Q
8-K Aug 13, 2025 8-K
8-K Aug 7, 2025 8-K
8-K Jul 31, 2025 FORM 8-K
4 Jul 30, 2025
8-K Jul 28, 2025 FORM 8-K
8-K Jul 17, 2025 8-K
8-K May 29, 2025 FORM 8-K
SCHEDULE 13G/A May 15, 2025
10-Q May 13, 2025 10-Q
8-K May 13, 2025 8-K
8-K May 1, 2025 FORM 8-K
ARS Apr 25, 2025 ARS
DEF 14A Apr 25, 2025 DEF 14A
S-3 Apr 18, 2025 S-3
PRE 14A Apr 15, 2025 PRE 14A
8-K Apr 14, 2025 8-K
10-K Mar 24, 2025 10-K
8-K Mar 24, 2025 8-K
8-K Mar 20, 2025 8-K
4 Feb 20, 2025 OWNERSHIP DOCUMENT
← Newer Page 2 of 33 · 808 filings Older →